Clinical Trial

Prilocaine for Sphenopalatine Ganglion Block in Endoscopic Hypophysectomy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 5, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
Patients undergoing endoscopic surgeries for pituitary adenoma excision suffer from wide swings in blood pressure that might increase bleeding and interfere with the surgical field. Local anethetic infiltration and regional nerve blocks have been used to provide better analgesia, control blood pressure and improve surgical field. Limited studies evaluated shenopalatine ganglion block in pituitary adenoma excision with promising outcomes. The proposed study will compare the efficacy of two local anesthetics, prilocaine and lidocaine, for spenopalatine ganglion block in patients undergoing endoscopic pituitary adenoma excision. Evaluating the control of the intraoperative blood pressure and analgesic sparing are the main objectives of the proposed study.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-16.
Status change: Not Yet Recruiting → Recruiting 2025-11-30
Trial Details
NCT Number NCT07188987
Lead Sponsor Kasr El Aini Hospital
Conditions Blood Pressure Control
Enrollment 54 participants
Start Date 2025-12-01
Primary Completion 2026-02 (estimated)
Study Completion 2026-02 (estimated)
Updated on ClinicalTrials.gov 2025-12-05